title: [Comparison of the echo-dobutamine-atropine test and ergometric test in the diagnosis of coronary disease].
abstract: BACKGROUND
  A prospective study has been done on 46 patients with suspected coronary artery disease (CAD). They had no history of myocardial infarction (MI) and a normal basal kinetic echocardiography. This was done in order to evaluate the overall accuracy of dobutamine-atropine stress echocardiography (DAS) compare to exercise stress test (ET) for the diagnosis of CAD.
  
  
  METHODS
  All the patients after suspension of coronary therapy, performed a casual sequence with both maximal or symptom limited exercise testing (treadmill-Bruce protocol) and DAS. The dobutamine has been given while monitoring systemic blood pressure, electrocardiography and echocardiography in steps of 10 mcg/kg/min' per 3 min' up to a maximum of 40 mcg/kg/min'. Atropine has been added (0.25-1 mg) in patients who did not reach the theoretical maximal cardiac frequency. The test is considered positive when kinetic segmental left ventricular dysfunction appeared. CAD was defined as 50% luminal area stenosis in at least 1 coronary artery at coronary angiography.
  
  
  RESULTS
  Significant CAD was present in 27/46 patients (59%). Compared with ET, DAS had significantly higher sensitivity (59% vs 92%, p = 0.01). The different sensibility between the two tests was higher on these patients with a 1 vessel disease (40% vs 86%, p = 0.02). There were no significant differences in specificity among the two tests (79% vs 84%, respectively). Differences in overall accuracy between ET and DAS were significant (67% vs 89%, p = 0.02).
  
  
  CONCLUSIONS
  The results of our study show that the DAS is a safe and feasible technique with high sensibility (especially in patients with single CAD) and specificity. This is a valid alternative to the traditional ET, especially for these patients unable to exercise or these who are poorly motivated to achieve a work load sufficient to make the test interpretable.
authors.affiliation: Divisione Di Cardiologia Utic Ospedale Buccheri La Ferla Fatebenefratelli, Palermo.
authors.forename: F M
authors.initials: FM
authors.lastname: Sarullo
authors.forename: R
authors.initials: R
authors.lastname: Schicchi
authors.forename: M
authors.initials: M
authors.lastname: Schirò
authors.forename: A M
authors.initials: AM
authors.lastname: Schillaci
authors.forename: A
authors.initials: A
authors.lastname: Ascione
authors.forename: G
authors.initials: G
authors.lastname: Bonnì
authors.forename: L
authors.initials: L
authors.lastname: Americo
authors.forename: G
authors.initials: G
authors.lastname: Orlando
authors.forename: S
authors.initials: S
authors.lastname: Andolina
authors.forename: M
authors.initials: M
authors.lastname: Adamo
authors.forename: A
authors.initials: A
authors.lastname: Castello
mesh_terms: D000328:Adult; D000368:Aged; D001285:Atropine / Q000009:adverse effects; D017023:Coronary Angiography; D003327:Coronary Disease / Q000175:diagnosis* / Q000000981:diagnostic imaging; D003627:Data Interpretation, Statistical; D004280:Dobutamine / Q000009:adverse effects; D004452:Echocardiography; D005080:Exercise Test / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012680:Sensitivity and Specificity
chemical_list: D004280:Dobutamine; D001285:Atropine